Success Metrics

Clinical Success Rate
66.7%

Based on 6 completed trials

Completion Rate
67%(6/9)
Active Trials
0(0%)
Results Posted
83%(5 trials)
Terminated
3(30%)

Phase Distribution

Ph not_applicable
7
70%
Ph phase_3
2
20%
Ph phase_4
1
10%

Phase Distribution

0

Early Stage

0

Mid Stage

3

Late Stage

Phase Distribution10 total trials
Phase 3Large-scale testing
2(20.0%)
Phase 4Post-market surveillance
1(10.0%)
N/ANon-phased studies
7(70.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

66.7%

6 of 9 finished

Non-Completion Rate

33.3%

3 ended early

Currently Active

0

trials recruiting

Total Trials

10

all time

Status Distribution
Completed(6)
Terminated(3)
Other(1)

Detailed Status

Completed6
Terminated3
unknown1

Development Timeline

Analytics

Development Status

Total Trials
10
Active
0
Success Rate
66.7%
Most Advanced
Phase 4

Trials by Phase

Phase 32 (20.0%)
Phase 41 (10.0%)
N/A7 (70.0%)

Trials by Status

terminated330%
completed660%
unknown110%

Recent Activity

Clinical Trials (10)

Drug Details

Intervention Type
DEVICE
Total Trials
10